Take a look at the agenda…
Additional speakers being added!

8:45 a.m. – 9:00 a.m.

Welcome & Opening Remarks

Debbie Hart, President & CEO, BioNJ

9:00 a.m. – 9:30 a.m.

Setting the Stage

Kickstart the day with an insightful perspective on how the industry responded and adapted to the pandemic and how these changes will shape the future of the industry.

Andrea Gennari, MBA, Partner, McKinsey & Company

9:30 a.m. – 10:30 a.m.

Panel: Vaccines & Therapeutics – Emergence of New Technologies & Approaches

Big trends in COVID-19 vaccines and therapeutics during the pandemic featuring best practices, lessons learned and the emergence of new technologies…at lightning speed to market.

Panelists:
	Annalisa Caterina Barile, Vice President and General Manager, Pharma Services Group, ThermoFisher Scientific
	Ryan Saadi, M.D., MPH, Chairman & Chief Executive Officer, Tevogen Bio
	Pamela Siwik, MBA, Vice President, Pfizer Global Supply, New Modalities New Product Lead, Pfizer
Moderator:
	Katie Kelleher, MBA, Associate Partner, McKinsey & Company

10:30 a.m. – 11:00 a.m.

Fireside Chat: The Moderna Story with Two Moderna Leaders

This conversation will highlight the riveting Moderna journey in getting the COVID-19 vaccine approved, manufactured and into the marketplace in record time, including getting non-existent manufacturing facilities and supply chain systems up and running as well as materials, workforce and site challenges along the way.

	Juan Andres, Chief Technical Operations and Quality Officer, Moderna
	Francois Nader, M.D., MBA, Independent Board Director, Moderna

11:00 a.m. – 11:15 a.m.

Break

11:15 a.m. – 12:15 p.m.

Panel: Impact of COVID-19 on Broader Pharma Manufacturing & Supply Chain

The effects of the COVID-19 pandemic on the broader biopharma network are and will continue to be real and dramatic, including supply chain resiliency, increased demand faced by suppliers and impact of working remotely. This session will feature experts who are grappling with, recovering from and building on the fallout.

Panelist:
	Melissa Buchanan, MBA, Director, Supply Chain, Catalent Biologics
	Jackie Elbonne, Ph.D., Chief Quality Officer & Senior Vice President of Global Quality, Bristol-Myers Squibb
	Peter Levison, Ph.D., MBA, Executive Director, Business Development, Pall Corporation
Moderator:
	Derron Stark, MBA, Managing Director, Strategy & Transactions, EY-Parthenon

12:15 p.m. – 12:45 p.m.

Case Study: Lessons Learned that are Here to Stay Beyond the Pandemic

The pandemic posed a unique set of challenges and required nimble responses to maintain manufacturing operations, ensure workforce safety and maximize supply chain resiliency. Hear a case study on how Thermo Fisher Scientific answered the call along with lasting takeaways for a post-pandemic world. 

Konrad Bauer, Senior Vice President, Global Business Services, Thermo Fisher Scientific

12:45 p.m. – 1:00 p.m.

Break

1:00 p.m. – 1:45 p.m.

Keynote by Dr. Carlo De Notaristefani

Having had a hand in and a bird’s-eye view of the U.S. Government’s response to the pandemic and the rollout of the various vaccines, Dr. DeNotaristefani will provide a compelling and insightful account of his perspective.

Carlo De Notaristefani, Dr. Ing., Lead Advisor for Manufacturing & Supply Chain, Operation Warp Speed/Federal COVID-19 Response, CDN Advising

1:45 p.m. – 2:15 p.m.

Networking: Pain Points in the Industry

Engage with other industry professionals in breakout rooms where we’ll discuss:

	Addressing Talent Challenges in Manufacturing Topic Leader: Norm Stoffregen, Head of Gene Therapy Biologics, PTC Therapeutics
	Application of Industry 4.0 to Manufacturing of Cell & Gene Therapies Topic Leader: Amy Lamperti, Vice President, Commercialization, BioCentriq
	Challenges in GMP Facility Buildout Topic Leaders: David Kristjanson, PMP, Vice President, Life Sciences Advisory, CBRE Life Sciences Group
	Tom Sullivan, Senior Vice President, CBRE Life Sciences Group